Clinical Trial Update: A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating gentuximab plus paclitaxel in advanced gastric or gastroesophageal junction cancer is in Phase 1/2 with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Gentuximab (gentuximab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Advanced Gastric or Gastroesophageal Junction Cancer | Phase 1, Phase 2 | Status: UNKNOWN